Latest updates for Xgntx
Fresh curated links around XGNTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Gentex Q3 2026 Earnings Preview
- Gentex declares $0.12 dividend
- AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
webwire.com
/1 month ago
AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”
AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...
seekingalpha.com
/16 hours ago
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript
seekingalpha.com
/4 weeks ago
NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation...
seekingalpha.com
/1 month ago
Genfit S.A. (GNFTF) Presents at H.C. Wainwright 28th Annual Global Investment Conference - Slideshow
cafepharma.com
/3 days ago
Argenx
Argenx Anonymous (not verified) Mon, 10/19/2026 - 10:14 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
seekingalpha.com
/1 month ago
Xenon Pharmaceuticals Inc. (XENE) Discusses Azetukalner NDA Submission for Focal Seizures and Psychiatry Program Update...
seekingalpha.com
/1 month ago
Xeris Biopharma Holdings, Inc. (XERS) Discusses XP-8121 Program Overview, Phase 3 Study Details and Commercial Strategy...
seekingalpha.com
/1 month ago
GXO Logistics, Inc. (GXO) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
seekingalpha.com
/4 weeks ago
GAMCO Natural Resources, Gold & Income Trust Q2 2026 Commentary
seekingalpha.com
/1 week ago
GNT And GNT.PR.A: Balancing Yield, Security, And Interest Rate Risk
seekingalpha.com
/1 month ago
Cognyte Software Ltd. 2027 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/2 weeks ago
XNTK: An Equally Weighted And Narrow Universe Of High-Growth Technology Stocks
seekingalpha.com
/1 week ago
Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways
seekingalpha.com
/1 month ago
SpyGlass Pharma, Inc. (SGP) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
biopharmadive.com
/2 weeks ago
Argenx falls as Sjögren’s setback offsets celiac drug progress
A monitoring board’s recommendation to stop the study for futility took Wall Street by surprise, removing one more ‘blockbuster expansion opportunity’ for Vyvgart.
seekingalpha.com
/1 month ago
Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial - Slideshow
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Xgntx
rssfeeds.webwire.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
biopharmadive.com
Recent coverage from public sources
Public source